Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-91.48	16.50	193.80
Graham Fair Price	137.98	17.83	7.49
PEG	-99.59	0.01	-2.96
Price/Book	-11.72	1.28	1.45
Price/Cash Flow	18.55	-33.46	28.23
Prices/Earnings	-82.66	5.13	29.59
Price/Sales	65.42	7.72	4.67
Price/FCF	18.55	-33.46	28.23
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	6.01	0.33	0.31
Operating Margin	-2620.29	-0.04	< 0.005
ROA	459.21	0.03	< 0.005
ROE	0.01	0.06	409.20
ROIC	< 0.005	< 0.005	-1558.38
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.21	0.43	-51.95
Dividends QOQ	0.60	-0.18	-69.84
EBIT QOQ	-1.03	-14.31	-1284.13
EPS QOQ	-0.10	4.22	4122.22
FCF QOQ	4.11	-1.79	-56.54
Revenue QOQ	0.42	-0.44	5.15
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	122.30	246.41	101.49
Days Sales Outstanding (DSO)	180.45	303.64	68.27
Inventory Turnover	0.74	0.37	-50.37
Debt/Capitalization	0.37	0.31	-17.44
Quick Ratio	1.34	1.41	4.54
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	14.26	15.04	5.46
Cash	10.22	8.53	-16.56
Capex	-0.36	-0.28	22.62
Free Cash Flow	0.73	-0.58	-21.47
Revenue	4.44	2.50	-43.72
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.65	1.82	10.63
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.19	-1.55	-90.46
Naive Interpretation	Member

06 - Financial Health · Weak

Rating